drugset / Trial / NCT05093881

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

NCT05093881 ↗

Recruiting 100 enrolled Pharmicell Co., Ltd.
NaSingle-groupOpen-labelOther

Summary

This Long-term follow-up is designed to evaluate the safety of patient with Alcoholic Liver Cirrhosis who had administered Cellgram-LC in PMC-P-07 study.

Timeline

Start
2021-08-24
Primary completion
2026-08-24
Completion
2028-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Cellgram-LC Unknown — —